Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis

Methotrexate efficacy and tolerability after switching from oral to subcutaneous route of administration in juvenile idiopathic arthritis

Objectives : Methotrexate (MTX) is one of the most frequently used, highly effective disease-modifying drugs in juvenile idiopathic arthritis (JIA) therapy. The drug can be administered orally or subcutaneously, but the efficacy and tolerance of these two routes of administration raise doubts in JIA...

Full description

Bibliographic Details
Main Authors: Zbigniew Żuber, Dorota Turowska-Heydel, Małgorzata Sobczyk, Marta Banach-Górnicka, Katarzyna Rusnak, Anna Piszczek, Elżbieta Mężyk
Format: Article
Language:English
Published: Termedia Publishing House 2016-03-01
Series:Rheumatology
Subjects:
juvenile idiopathic arthritis
methotrexate
subcutaneous administration
oral administration
Online Access:http://www.termedia.pl/Methotrexate-efficacy-and-tolerability-after-switching-from-oral-to-subcutaneous-route-of-administration-in-juvenile-idiopathic-arthritis,18,27170,1,1.html

Internet

http://www.termedia.pl/Methotrexate-efficacy-and-tolerability-after-switching-from-oral-to-subcutaneous-route-of-administration-in-juvenile-idiopathic-arthritis,18,27170,1,1.html

Similar Items